Ye Weizhen, Mairet-Coello Georges, Pasoreck Elise, Dicicco-Bloom Emanuel
Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
Dev Neurobiol. 2009 Jan;69(1):1-21. doi: 10.1002/dneu.20680.
In developing central nervous system, a variety of mechanisms couple cell cycle exit to differentiation during neurogenesis. The cyclin-dependent kinase (CDK) inhibitor p57Kip2 controls the transition from proliferation to differentiation in many tissues, but roles in developing brain remain uncertain. To characterize possible functions, we defined p57Kip2 protein expression in embryonic (E) day 12.5 to 20.5 rat brains using immunohistochemistry combined with markers of proliferation and differentiation. The p57Kip2 was localized primarily in cell nuclei and positive cells formed two distinct patterns including wide dispersion and laminar aggregation that were brain region-specific. From E12.5 to E16.5, p57Kip2 expression was detected mainly in ventricular zone (VZ) and/or mantle zone of hippocampus, septum, basal ganglia, thalamus, hypothalamus, midbrain, and spinal cord. After E18.5, p57Kip2 was detected in select regions undergoing differentiation. The p57Kip2 expression was also compared with regional transcription factors, including Ngn2, Nkx2.1, and Pax6. Time course studies performed in diencephalon showed that p57Kip2 immunoreactivity colocalized with BrdU at 8 hr in nuclei exhibiting the wide dispersion pattern, whereas colocalization in the laminar pattern occurred only later. Moreover, p57Kip2 frequently colocalized with neuronal marker, beta-III tubulin. Finally, we characterized relationships of p57Kip2 to CDK inhibitor p27Kip1: in proliferative regions, p57Kip2 expression preceded p27Kip1 as cells underwent differentiation, though the proteins colocalized in substantial numbers of cells, suggesting potentially related yet distinct functions of Cip/Kip family members during neurogenesis. Our observations that p57Kip2 exhibits nuclear expression as precursors exit the cell cycle and begin expressing neuronal characteristics suggests that the CDK inhibitor contributes to regulating the transition from proliferation to differentiation during brain development.
在中枢神经系统发育过程中,多种机制在神经发生期间将细胞周期退出与分化联系起来。细胞周期蛋白依赖性激酶(CDK)抑制剂p57Kip2控制许多组织中从增殖到分化的转变,但在发育中的大脑中的作用仍不确定。为了表征其可能的功能,我们使用免疫组织化学结合增殖和分化标记物,确定了胚胎(E)第12.5天至20.5天大鼠大脑中p57Kip2蛋白的表达。p57Kip2主要定位于细胞核,阳性细胞形成两种不同的模式,包括广泛分散和层状聚集,这是脑区特异性的。从E12.5到E16.5,p57Kip2表达主要在海马、隔区、基底神经节、丘脑、下丘脑、中脑和脊髓的脑室区(VZ)和/或套层区检测到。E18.5之后,在进行分化的特定区域检测到p57Kip2。还将p57Kip2表达与区域转录因子进行了比较,包括Ngn2、Nkx2.1和Pax6。在间脑中进行的时间进程研究表明,p57Kip2免疫反应性在8小时时与BrdU在呈现广泛分散模式的细胞核中共定位,而层状模式中的共定位仅在稍后发生。此外,p57Kip2经常与神经元标记物β-III微管蛋白共定位。最后,我们表征了p57Kip2与CDK抑制剂pKip1的关系:在增殖区域,随着细胞分化,p57Kip2表达先于p27Kip1,尽管这两种蛋白在大量细胞中共定位,这表明Cip/Kip家族成员在神经发生过程中可能具有相关但不同的功能。我们观察到,当神经前体细胞退出细胞周期并开始表达神经元特征时,p57Kip2表现出核表达,这表明CDK抑制剂有助于调节大脑发育过程中从增殖到分化的转变。